Scarica l'app Stockscreener
1.17
2.50%
-0.03
Dopo l'orario di chiusura:
1.17
Precedente Chiudi:
$1.20
Aprire:
$1.16
Volume 24 ore:
999.92K
Relative Volume:
0.97
Capitalizzazione di mercato:
$117.42M
Reddito:
-
Utile/perdita netta:
$-20.31M
Rapporto P/E:
-4.4234
EPS:
-0.2645
Flusso di cassa netto:
$-21.07M
1 W Prestazione:
-13.97%
1M Prestazione:
-8.59%
6M Prestazione:
+87.83%
1 anno Prestazione:
-6.40%
Intervallo 1D:
$1.14
$1.22
Intervallo di 1 settimana:
$1.14
$1.39
Portata 52W:
$0.3258
$1.51
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Nome
Oncolytics Biotech Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ONCY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.17 | 121.50M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-13 | Iniziato | Lake Street | Buy |
| 2022-10-06 | Iniziato | Maxim Group | Buy |
| 2021-02-17 | Iniziato | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Borsa (ONCY) Ultime notizie
Published on: 2025-10-13 08:31:55 - newser.com
Relative strength of Oncolytics Biotech Inc. in sector analysis2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Is Oncolytics Biotech Inc. stock overvalued by current metricsMarket Risk Analysis & Scalable Portfolio Growth Methods - newser.com
Published on: 2025-10-13 07:15:35 - newser.com
Oncolytics Biotech Inc. (NASDAQ:ONCY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy - TipRanks
Understanding Oncolytics Biotech Inc.’s price movementMarket Growth Summary & Weekly Breakout Watchlists - newser.com
Oncolytics Biotech's (ONCY) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat
Is Oncolytics Biotech Inc. reversing from oversold territoryGold Moves & Real-Time Stock Entry Alerts - newser.com
Oncolytics Biotech (NASDAQ:ONCY) Trading Down 3.1%Should You Sell? - MarketBeat
Oncolytic Virus Therapy Market Size to Hit USD 11.13 Billion by 2034 - Precedence Research
Volatility clustering patterns for Oncolytics Biotech Inc.Market Sentiment Review & Weekly Consistent Profit Watchlists - newser.com
Is Oncolytics Biotech Inc. forming a bottoming baseJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com
Is Oncolytics Biotech Inc. stock positioned for long term growthTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Published on: 2025-10-03 07:12:20 - newser.com
Using RSI to spot recovery in Oncolytics Biotech Inc.July 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Candlestick signals on Oncolytics Biotech Inc. stock todayMarket Movement Recap & Community Driven Trade Alerts - newser.com
Oncolytics Biotech unveils design for pancreatic cancer registration trial By Investing.com - Investing.com Canada
Is Oncolytics Biotech Inc a good long term investmentTrading Volume Trends & Access Our Free Weekly Investment Letter - earlytimes.in
What Makes Vision Corporation Limited Stand Out Among CompetitorsDouble Top/Bottom Patterns & Big Gains Small Budget - earlytimes.in
Stocks in play: Oncolytics Biotech Inc. - The Globe and Mail
Oncolytics Biotech Advances Pancreatic Cancer Trial with Innovative Design - TipRanks
Oncolytics Biotech announces update for potential first-line pancreatic cancer registration study - MarketScreener
Oncolytics Biotech® Announces Update for Potential First-Line Pa - GuruFocus
Stocks In Play: Oncolytics Biotech Inc - Barchart.com
Oncolytics Biotech unveils design for pancreatic cancer registration trial - Investing.com India
How Oncolytics Biotech Inc. stock trades before earningsLong Setup & Accurate Entry/Exit Alerts - newser.com
Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study - PR Newswire
What analysts say about Oncolytics Biotech Inc stockMean Reversion Trades & Free Daily Top Stock Picks for All Investors - earlytimes.in
What drives Oncolytics Biotech Inc stock priceReal-Time Stock Alerts & See Risk Factors Before Making Any Move - earlytimes.in
Oncolytics Biotech Inc Stock Analysis and ForecastStock Price Targets & High Return Investment Plans - earlytimes.in
Oncolytics Biotech Inc. stock trend outlook and recovery pathJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Published on: 2025-09-26 15:22:59 - newser.com
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone - Investing News Network
Q3 EPS Estimates for Oncolytics Biotech Cut by HC Wainwright - MarketBeat
Applying chart zones and confluence areas to Oncolytics Biotech Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Oncolytics Biotech Inc. (NASDAQ:ONCY) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Oncolytics Biotech (NASDAQ:ONCY) Stock Price Down 3.1%Time to Sell? - MarketBeat
Meme Stocks: Is Oncolytics Biotech Inc a top pick in the sector2025 Performance Recap & Free Community Consensus Stock Picks - خودرو بانک
Breakouts Watch: Will Tyson Foods Inc. outperform tech stocksCEO Change & Technical Entry and Exit Alerts - khodrobank.com
Wall Street Recap: What are Oncolytics Biotech Incs earnings expectationsEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Oncolytics Biotech Inc Azioni (ONCY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):